2m 2m 2m 2m 2m 2m 2m
BAUSCH HEALTH (BHC)
NYSE
$4.80-$0.0010 (-0.02%)
Price as of Jun 23, 2026 8:00 PM EDT- $1.7BMarket Cap
- -23.44%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BAUSCH HEALTH (BHC)
$4.80-$0.0010 (-0.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 10.2B +5.52% | 9.6B +9.91% | 8.8B +7.79% | 8.1B -3.68% | |
Cost of Revenue | 2.9B -47.00% | 5.6B +117.43% | 2.6B +8.25% | 2.4B -1.25% | |
Gross Profit | 7.2B +77.47% | 4.1B -34.48% | 6.2B +7.60% | 5.8B -4.64% | |
Sales and Marketing Expense | 3.4B +4.31% | 3.3B +12.99% | 2.9B +11.12% | 2.6B +0.04% | |
Research and Development Expense | -629.0M +2.11% | -616.0M +1.99% | -604.0M +14.18% | -529.0M +13.76% | |
Depreciation and Amortization Expense | 1.2B -4.66% | 1.3B +0.24% | 1.3B -9.33% | 1.4B -10.18% | |
Total Operating Expenses | 8.5B +4.63% | 8.1B +3.66% | 7.8B +1.62% | 7.7B -3.93% | |
Operating Profit | 1.8B +17.27% | 1.5B +60.54% | 963.0M +112.11% | 454.0M +0.89% | |
Interest Income | 48.0M +45.45% | 33.0M +26.92% | 26.0M +85.71% | 14.0M +100.00% | |
Interest Expense | -1.6B +15.56% | -1.4B +4.52% | -1.3B -9.29% | -1.5B +2.66% | |
Interest Income and Expense and Net | -1.6B +14.83% | -1.4B +4.07% | -1.3B -10.21% | -1.4B +2.18% | |
Total Nonoperating Income and Expense | -142.0M -42.51% | -247.0M +782.14% | -28.0M -20.00% | -35.0M -90.62% | |
Income before Taxes | 367.0M +119.76% | 167.0M +142.82% | -390.0M +202.33% | -129.0M -87.40% | |
Income Taxes | 247.0M +3.35% | 239.0M +8.14% | 221.0M +166.27% | 83.0M +195.40% | |
Extraordinary Items | 8.0M -72.41% | 29.0M -46.30% | 54.0M +260.00% | 15.0M -93.59% | |
Net Income | 157.0M +441.30% | -46.0M -92.23% | -592.0M +163.11% | -225.0M -76.27% | |
Net Income from Continuing Operations Applicable to Common | 367.0M +119.76% | 167.0M +142.82% | -390.0M +202.33% | -129.0M -87.40% | |
Basic EPS and Net Income | 0.42 +423.08% | -0.13 -91.98% | -1.62 +161.29% | -0.62 -76.52% | |
Diluted EPS and Net Income | 0.42 +423.08% | -0.13 -91.98% | -1.62 +161.29% | -0.62 -76.52% | |
Basic Weighted Average Shares | 370.9M +0.79% | 368.0M +0.85% | 364.9M +0.80% | 362.0M +0.86% | |
Diluted Weighted Average Shares | 375.0M +1.90% | 368.0M +0.85% | 364.9M +0.80% | 362.0M +0.86% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.3B +10.84% | 1.2B +24.71% | 947.0M +67.91% | 564.0M -3.09% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.3B +10.84% | 1.2B +24.71% | 947.0M +67.91% | 564.0M -3.09% | |
Total Current Assets | 6.2B +6.63% | 5.8B +3.18% | 5.6B +31.76% | 4.2B -24.26% | |
Accumulated Depreciation | 2.4B +13.06% | 2.1B +2.93% | 2.1B +8.49% | 1.9B +5.49% | |
Property and Plant and Equipment and Net | 2.1B +16.52% | 1.8B +4.28% | 1.7B +6.69% | 1.6B +0.13% | |
Total Long-Term Assets | 378.0M +4.13% | 363.0M +18.24% | 307.0M -5.83% | 326.0M -4.12% | |
Total Assets | 26.4B -0.59% | 26.5B -3.02% | 27.4B +6.48% | 25.7B -12.04% | |
Income Taxes Payable | 147.0M +14.84% | 128.0M -21.47% | 163.0M -19.31% | 202.0M -61.81% | |
Total Short-Term Debt | 225.0M -91.59% | 2.7B +494.22% | 450.0M +4.17% | 432.0M N/A | |
Total Current Liabilities | 4.2B -38.09% | 6.8B +56.95% | 4.3B +9.16% | 3.9B -24.18% | |
Total Long-Term Debt | 20.6B +8.71% | 18.9B -13.66% | 21.9B +7.89% | 20.3B -10.24% | |
Total Long-Term Liabilities | 793.0M +11.22% | 713.0M -8.12% | 776.0M +4.72% | 741.0M +13.48% | |
Total Liabilities | 26.0B -3.19% | 26.8B -2.14% | 27.4B +7.89% | 25.4B -13.03% | |
Retained Earnings | -9.7B -1.60% | -9.8B +0.47% | -9.8B +6.44% | -9.2B +2.51% | |
Total Stockholders Equity | -554.0M -56.68% | -1.3B +25.15% | -1.0B +47.69% | -692.0M +552.83% | |
Total Shares Outstanding | 370.5M +0.73% | 367.8M +0.71% | 365.2M +0.92% | 361.9M +0.69% | |
Cash Flow | |||||
Cash from Operating Activities | 1.4B -12.34% | 1.6B +54.75% | 1.0B +241.76% | -728.0M -151.05% | |
Capital Expenditures | 397.0M +17.80% | 337.0M +56.74% | 215.0M -1.38% | 218.0M -18.96% | |
Cash from Investing Activities | -595.0M +31.06% | -454.0M -78.83% | -2.1B +607.92% | -303.0M -174.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -742.0M -14.52% | -868.0M -158.85% | 1.5B +411.18% | -474.0M -68.67% | |
Financials Ratio | |||||
Gross Margin | 70.96% +68.19% | 42.19% -40.39% | 70.78% -0.17% | 70.90% -1.00% | |
Operating Margin | 17.85% +11.14% | 16.06% +46.06% | 11.00% +96.78% | 5.59% +4.74% | |
Return on Assets | 0.59% +447.60% | -0.17% -92.35% | -2.23% +172.28% | -0.82% -73.88% | |
Return on Equity | -17.13% -528.44% | 4.00% -94.21% | 69.08% +22.50% | 56.39% +112.76% | |
Revenue Growth | 5.52% -44.34% | 9.91% +27.21% | 7.79% +311.98% | -3.68% -172.49% | |
Current Ratio | 1.47 +72.24% | 0.86 -34.26% | 1.30 +20.71% | 1.08 -0.10% | |
Cash Ratio | 0.31 +79.07% | 0.17 -20.54% | 0.22 +53.81% | 0.14 +27.77% | |
Debt-to-Equity Ratio | -37.58 +122.33% | -16.90 -22.85% | -21.91 -27.00% | -30.01 -85.96% | |
Debt-to-Assets Ratio | 0.79 -3.13% | 0.82 -0.44% | 0.82 +1.25% | 0.81 +4.22% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow